Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
Title: | Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial |
---|---|
Authors: | Mehran Zarghami, Aroona Chabra, Mohammad Azadbakht, Alireza Khalilian, Ali Asghar Hoseini |
Source: | Research Journal of Pharmacognosy, Vol 5, Iss 3, Pp 15-20 (2018) |
Publisher Information: | Iranian Society of Pharmacognosy, 2018. |
Publication Year: | 2018 |
Collection: | LCC:Pharmacy and materia medica |
Subject Terms: | Asperugo procumbens, badranjbuyeh, Depression, fluoxetine, Pharmacy and materia medica, RS1-441 |
More Details: | Background and objectives: Aseprugo procumbens is used as antianxety and depression in Iranian traditional medicine; however no clinical trial has been performed about these properties. The aim of this study was to evaluate the antidepressant efficacy and safety of hydroalcoholic extract of A. procumbens. Methods: In this double blind study, 30 outpatients with mild to moderate depressive disorder (according to DMS-IV-TR criteria who had a score of 18-25 on the Hamilton Depression Rating Scale (HDRS) were randomly divided in two group, 1) received 10 mg fluoxetine capsule, 2) received 1.2 g dried extract of A. procumbens capsule (6 mg flavonoid,) orally per day. Patients were followed up for 6 weeks; the recovery process was assessed by the HDRS in weeks 0, 2, 4 and 6. Results: A significant decrease in HDRS was observed in both groups after the fourth week. After the sixth week, fluoxetine had a greater anti-depressant activity than A. procumbens (p value =0.03). There were no significant differences in terms of adverse effects in both groups. Conclusions: The hydroalcoholic extract of A. procumbens can be considered as an effective and safe remedy for mild to moderate depressive disorder. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2345-4458 2345-5977 |
Relation: | http://www.rjpharmacognosy.ir/article_64860_3f60b43d8238c9a451f59d5fa6d87dd9.pdf; https://doaj.org/toc/2345-4458; https://doaj.org/toc/2345-5977 |
DOI: | 10.22127/rjp.2018.64860 |
Access URL: | https://doaj.org/article/507c0663638f43829ed0da88f50edfcd |
Accession Number: | edsdoj.507c0663638f43829ed0da88f50edfcd |
Database: | Directory of Open Access Journals |
ISSN: | 23454458 23455977 |
---|---|
DOI: | 10.22127/rjp.2018.64860 |
Published in: | Research Journal of Pharmacognosy |
Language: | English |